Velarion Records
Free. Unsubscribe any time.

Nurix Therapeutics, Inc. (NRIX)

Nurix Therapeutics, Inc. filed 25 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 3 reporting owners, covering 32 transactions and 229,044 shares. None carries the SEC's AFF10B5ONE flag; all 25 name a plan in a footnote. 8 results prints are on file in the same window.

What stands out

Trades in Nurix Therapeutics, Inc. 32

Adoption dates in Nurix Therapeutics, Inc. 0

Results prints in Nurix Therapeutics, Inc. 8

Trades before a print in Nurix Therapeutics, Inc. 0

Interval to Nurix Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.

The address of this record

Nurix Therapeutics, Inc.’s insider trading plan record — 25 Form 4 statements in the 2025 filing year — is published at one address, this page. When you cite or link the record, use https://velarionrecords.com/plan10b5/issuer/0001549595.